Cited by 1,259

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

Maron, Martin S., Olivotto, Iacopo, Betocchi, Sandro, Casey, Susan A., Lesser, John R., Losi, Maria A., Cecchi, Franco, Maron, Barry J.·2003·New England Journal of Medicine

Abstract

Background The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved. Methods We assessed the effect of outflow tract obstruction on morbidity and mortality in a large cohort of patients with hypertrophic cardiomyopathy who were followed for a mean (+/-SD) of 6.3+/-6.2 years. Results Of the 1101 consecutive patients, 273 (25 percent) had obstruction of left ventricular outflow under basal (resting) conditions with a peak instantaneous gradient of at least 30 mm Hg. A total of 127 patients (12 percent) died of hypertrophic cardiomyopathy, and 216 surviving patients (20 percent) had severe, disabling symptoms of progressive heart failure (New York Heart Association [NYHA] functional class III or IV). The overall probability of death related to hypertrophic cardiomyopathy was significantly greater among patients with outflow tract obstruction than among those without obstruction (relative risk, 2.0; P=0.001). The risk of progression to NYHA class III or IV or death specifically from heart failure or stroke was also greater among patients with obstruction (relative risk, 4.4; P Conclusions In patients with hypertrophic cardiomyopathy, left ventricular outflow tract obstruction at rest is a strong, independent predictor of progression to severe symptoms of heart failure and of death.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa021332

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LVOT obstruction has been identified as a predictor of sudden death in some but not all studies.

    “LVOT obstruction has been identified as a predictor of sudden death in some but not all studies”

    From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [105]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. 10.1016/0033-0620(85)90024-6 · DOI
  2. Braunwald E, 1964, Circulation, 30, IV
  3. Wigle ED, 1995, Circulation, 92, 1680, 10.1161/01.CIR.92.7.1680 · DOI
  4. Frank S, 1968, Circulation, 37, 759, 10.1161/01.CIR.37.5.759 · DOI
  5. 10.1056/NEJM199703133361107 · DOI
  6. Shah PM, 1974, Circ Res, 35, 179
  7. 10.1016/S0002-9149(98)00455-X · DOI
  8. 10.1001/jama.281.7.650 · DOI
  9. 10.1016/0735-1097(95)00353-3 · DOI
  10. 10.1016/S0735-1097(00)01003-2 · DOI
  11. 10.1056/NEJM200006153422403 · DOI
  12. 10.1172/JCI109990 · DOI
  13. Kizilbash AM, 1998, Circulation, 97, 461, 10.1161/01.CIR.97.5.461 · DOI
  14. Romeo F, 1990, Eur Heart J, 11, 233, 10.1093/oxfordjournals.eurheartj.a059689 · DOI
  15. 10.1016/S0735-1097(10)80266-9 · DOI
  16. Panza JA, 1992, Circulation, 85, 1398, 10.1161/01.CIR.85.4.1398 · DOI
  17. 10.1161/01.CIR.72.6.1148 · DOI
  18. 10.1016/S0735-1097(85)80244-8 · DOI
  19. 10.1016/0735-1097(91)90596-2 · DOI
  20. 10.1056/NEJM199609263351305 · DOI · Paper page
  21. 10.1016/0735-1097(92)90057-T · DOI
  22. McCully RB, 1996, Circulation, 94, 467, 10.1161/01.CIR.94.3.467 · DOI
  23. 10.1016/S0735-1097(00)01019-6 · DOI
  24. 10.1016/S0140-6736(95)91267-3 · DOI
  25. 10.1016/S0735-1097(01)01656-4 · DOI
  26. 10.1016/0002-9149(81)90605-6 · DOI
  27. Henry WL, 1980, Circulation, 62, 1054, 10.1161/01.CIR.62.5.1054 · DOI
  28. 10.1016/0735-1097(95)00390-8 · DOI
  29. Maron BJ, 2000, Circulation, 102, 858, 10.1161/01.CIR.102.8.858 · DOI · Paper page
  30. 10.1161/hc4601.097997 · DOI · Paper page
  31. 10.1161/01.CIR.75.1.175 · DOI
  32. Wigle ED, 1967, Circulation, 35, 1100, 10.1161/01.CIR.35.6.1100 · DOI
  33. Ross J, 1966, Circulation, 34, 558, 10.1161/01.CIR.34.4.558 · DOI
  34. Sherrid MV, 1998, Circulation, 97, 41, 10.1161/01.CIR.97.1.41 · DOI
  35. 10.1056/NEJM198703263161305 · DOI
  36. 10.1056/NEJM200002103420601 · DOI · Paper page
  37. 10.1016/S0735-1097(86)80181-4 · DOI
  38. 10.1161/01.CIR.71.2.234 · DOI
  39. 10.1016/S0735-1097(10)80145-7 · DOI

Cited by

Sorted by citations

Metadata

Authors
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J.
Venue
New England Journal of Medicine
Published
2003-01-23
Volume
348
Issue
4
Pages
295-303
ISSN
  • 0028-4793
  • 1533-4406
Cited by
1,259
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review